Skip to main navigation Skip to search Skip to main content

Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer—a commentary from the Young International Society of Geriatric Oncology

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)555-556
Number of pages2
JournalAnnals of Oncology
Volume34
Issue number6
DOIs
StatePublished - Jun 2023

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this